KA

Kannivel Amudha

Active Director Director DIN 08412257
DIN 08412257 First appointment Apr 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2019
Shareholding value •••• Premium profile

About Kannivel Amudha

Data last updated:

Kannivel Amudha is a Director at Viswak Pharma Private Limited (since 2019). The company operates in Pharma. Viswak Pharma Private Limited reported revenue of ₹36.43 Cr (FY 2025).

DIN 08412257
Primary Designation Director
Industry Pharma
First Appointment 22 Apr 2019
Oldest Company Age 7 yrs
Largest company Viswak Pharma Private Limited · ₹36.43 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Viswak Pharma Private Limited U51397TN2019PTC128841
Director22 Apr 20192019₹36.43 Cr (FY 2025)Active

Board colleagues of Kannivel Amudha

NameDINCompanyDesignation
Lakshmi08412265Viswak Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Viswak Pharma Private Limited
Premium access

Shareholding and investment profile for Kannivel Amudha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kannivel Amudha

Kannivel Amudha currently holds 1 directorship: Viswak Pharma Private Limited (Director, since 22 Apr 2019, revenue ₹36.43 Cr (FY 2025)).

Kannivel Amudha was first appointed on 22 Apr 2019 as Director at Viswak Pharma Private Limited.

The current boards of Kannivel Amudha's companies include Lakshmi (Viswak Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available